NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Cent Raises $5 Million in Seed Funding from South Park Commons and OneFlow Holdings

Background

Cent, a preventive healthcare startup, has secured $5 million in seed funding from South Park Commons and family office OneFlow Holdings. The company was founded in 2025 by Shashank ND, Arpit Garg, and Anshul Khandelwal, who have also raised funds from OneFlow Holdings, which is the family office of Practo's Shashank ND.

Company Overview

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

Cent is an AI-led platform focused on early detection of cancer, cardiac, neurological, and metabolic risks in individuals before symptoms appear. The company aims to make people live until they are 100 years old, which is reflected in its name, "Cent" (short for Century).

Product and Services

Cent combines advanced imaging with over 120 biomarkers and AI-driven analysis to screen for over 300 health conditions in a single visit. The company's screening model is built around a proprietary protocol called CCNM (Cardiac, Cancer, Neurological and Metabolic), which integrates whole-body MRI, low-dose CT, DEXA scans, ECG, and blood and urine biomarkers, along with AI-driven synthesis to generate organ-level risk assessments followed by clinical consultation.

Performance

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

Cent has been operational since the first quarter of FY26 and has completed over 1,500 scans so far. According to the company, 26% of these scans revealed clinically meaningful findings, while 4% identified critical conditions requiring immediate medical attention, largely among individuals who were asymptomatic at the time.

Growth and Expansion

Cent is currently growing 50% month-on-month and has reached an annualised revenue run rate of around $2 million. The company aims to complete 50,000 scans this year as it expands capacity. Cent is also building a network of single-purpose detection centres, with the first facilities expected to roll out beginning April 2026 across Mumbai, Delhi, and Bengaluru, followed by expansion into Pune and Hyderabad.

Long-term Ambition

Cent's long-term ambition is to enable 10 million scans and contribute to 1 million lives saved by 2035, as it looks to make early detection a more mainstream part of healthcare in India.

Investor Takeaway

Investors should consider the potential long-term growth of preventive healthcare startups like Cent.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.